Updated Jul 16, 2026
Cooper Ronald Harold Wilfred has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $57K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-09 | GBIO | Generation Bio Co. | J — Other acquisition / disposition | 950 | — | |
| 2024-10-01 | ENGN | enGene Therapeutics Inc. | P — Open-market purchase | 10.0K | $5.70 | $57K |
Cooper Ronald Harold Wilfred is a corporate insider — currently tracked as Director of C4 Therapeutics, Inc. (CCCC). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($57K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cooper Ronald Harold Wilfred profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.